Review: Biology and relevance of C-reactive protein in cardiovascular and renal disease

Annals of Clinical and Laboratory Science

Volumn 30, Issue 2, 2000, Pages 133-144

  Westhuyzen, Justin ^a   Healy, Helen ^a  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

Acute phase reactants; Ardiovascular disease; C reactive protein; End stage renal failure; Pentraxins

Indexed keywords

C REACTIVE PROTEIN;

CARDIOVASCULAR DISEASE; HUMAN; INFLAMMATION; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; URINARY TRACT INFECTION;

C-REACTIVE PROTEIN; CORONARY DISEASE; HUMANS; KIDNEY FAILURE, CHRONIC;

EID: 0034007344     PISSN: 00917370     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (97)

1. Gewurz H, Zhang XH, Lint TF. Structure and function of the pentraxins. Curr Opin Immunol 1995;7:54-64.
2. Gebay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999;340:448-454.
3. Pepys MB. C-reactive protein fifty years on. Lancet 1981;1:653-657.
4. Zhong W, Zen Q, Tebo J, Schlottmann K, Coggeshall M, Mortensen RF. Effect of human C-reactive protein on chemokine and chemotactic factor-induced neutrophil chemotaxis and signaling. J Immunol 1998;161:2533-2540.
5. Sim RB, Malhotra R. Interactions of carbohydrates and lectins with complement. Biochem Soc Trans 1994;22:106-111.
6. Ross R. Atherosclerosis is an inflammatory disease. Am Heart J 1999;138:5419-420.
7. Tracy RP. Inflammation in cardiovascular disease. Cart, horse, or both? Circulation 1998;97:2000-2002.
8. Danesh J, Collins R, Appleby P, Peto R. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA 1998;279:1477-1482.
9. Zimmerman J, Herrlinger S, Pruy A, Metzgler T, Wanner C. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 1999;55:648-658.
10. Stenvinkel P, Heimbürger O, Paultre F, Diczfalusy U, Wang T, Berglund L, Jogestrand T. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 1999;55:1899-1911.
11. Docci D, Bilancioni R, Buscaroli A, Baldrati L, Capponcini C, Mengozzi S, Turci F, Feletti C. Elevated serum levels of C-reactive protein in hemodialysis patients. Nephron 1990;6:364-367.
12. Gotschlich EC. C-reactive protein. A historical overview. Ann NY Acad Sci 1989;557:9-18.
13. Kolb-Bachofen V. A review of the biological properties of C-reactive protein. Immunobiol 1991;183:133-145.
14. Szalai AJ, Agrawal A, Greenhough TJ, Volanakis JE. C-reactive protein: structural biology, gene expression, and host defense function. Immunol Res 1997;16:127-136.
15. Goodman AR, Cardozo T, Abagyan R, Altmeyer A, Wisniewski HG, Vilcek J. Long pentraxins: an emerging group of proteins with diverse functions. Cytokine Growth Factor Rev 1996;7:191-202.
16. Tennent GA, Pepys MB. Glycobiology of the pentraxins. Biochem Soc Trans 1994;22:74-79.
17. Du Clos TW. The interaction of C-reactive protein and serum amyloid P component with nuclear antigens. Molec Biol Reports 1996;23:253-260.
18. Shrive AK, Cheetham GM, Holden D, Myles DA, Turnell WG, Volanakis JE, Pepys MB, Bloomer AC, Greenhough TJ. Three dimensional structure of human C-reactive protein. Nat Struct Biol 1996;3:346-354.
19. Sambasivam H, Rassouli M, Murray RK, Nagpurkar A, Mookerjea S, Azadi P, Dell A, Morris HR. Studies on the carbohydrate moiety and on the biosynthesis of rat C-reactive protein. J Biol Chem 1993;268:10007-100016.
20. Yue CC, Muller-Greven J, Dailey P, Lozanski G, Anderson V, Macintyre S. Identification of a C-reactive protein binding site in two hepatic carboxylesterases capable of retaining C-reactive protein within the endoplasmic reticulum. J Biol Chem 1996; 271:22245-22250.
21. Jilma B, Dirnberger E, Loscher I, Rumplmayr A, Hildebrandt J, Eichler HG, Kapiotis S, Wagner OF. Menstrual cycle-associated changes in blood levels of interleukin-6, alpha1 acid glycoprotein, and C-reactive protein. J Lab Clin Med 1997;130:69-75.
22. Vigushin DM, Pepys MB, Hawkins PN. Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease. J Clin Invest 1993;91:1351-1357.
23. Kuta AE, Baum LL. C-reactive protein is produced by a small number of human peripheral blood lymphocytes. J Exp Med 1986;164:321-326.
24. Murphy TM, Baum LL, Beaman KD. Extrahepatic transcription of human C-reactive protein. J Exp Med 1991;173:495-498.
25. Pepys MB, Booth SE, Tennent GA, Butler PJ, Williams DG. Binding of pentraxins to different nuclear structures: C-reactive protein binds to small nuclear ribonucleoprotein particles, serum amyloid P component binds to chromatin and nucleoli. Clin Exp Immunol 1994;97:152-157.
26. 125I-labeled modified C-reactive protein in CD-1 mice. Drug Metab Disposition 1998;26:977-981.
27. Shields MJ. A hypothesis resolving the apparently disparate activities of native and altered forms of human C-reactive protein. Immunologic Res 1993;12:37-47.
28. Laiho K, Tiitinen S, Teppo AM, Kauppi M, Kaarela K. Serum C-reactive protein is rarely lost into urine in patients with secondary amyloidosis and proteinuria. Clin Rheumatol 1998;17:234-235.
29. Schwalbe RA, Dahlback B, Coe JE, Nelsestuen GL. Pentraxin family of proteins interact specifically with phosphorylcholine and/or phosphorylethanolamine. Biochemistry 1992;31:4907-4915.
30. Bottazzi B, Vouret-Craviari V, Bastone A, De Gioia L, Matteucci C, Peri G, Spreafico F, Pausa M, D'Ettorre C, Gianazza E, Tagliabue A, Salmona M, Tedesco F, Introna M, Mantovani A. Multimer formation and ligand recognition by the long pentraxin PTX3. Similarities and differences with the short pentraxins C-reactive protein and serum amyloid P component. J Biol Chem 1997;272:32817-32823.
31. Christner RB, Mortensen RF. Specificity of the binding interaction between human serum amyloid P-component and immobilized human C-reactive protein. J Biol Chem 1994;269:9760-9766.
32. Agrawal A, Xu Y, Ansardi D, Macon KJ, Volanakis JE. Probing the phosphocholine-binding site of human C-reactive protein by site-directed mutagenesis. J Biol Chem 1992;267:25353-25358.
33. Mullenix MC, Kaumaya PT, Mortensen RF. Cell attachment peptide of C-reactive protein: critical amino acids and minimum length. J Cell Biochem 1994;54:343-353.
34. Zen Q, Zhong W, Mortensen RF. Binding site on human C-reactive protein (CRP) recognized by the leukocyte CRP-receptor. J Cell Biochem 1997;64:140-151.
35. Fernandez MC, Mullenix MC, Christner RB, Mortensen RF. A cell attachment peptide from human C-reactive protein. J Cell Biochem 1992;50:83-92.
36. Matsuo S, Morita Y, Mizuno M, Nishikawa K, Yuzawa Y. Proteinuria and damage to tubular cells - is complement a culprit? Nephrol Dial Transplant 1998;13:2723-2726.
37. Tang S, Sheerin NS, Zhou W, Brown Z, Sacks SH. Apical proteins stimulate complement synthesis by cultured human proximal tubular cells. J Am Soc Nephrol 1999;10:69-76.
38. Miyazawa K, Inoue K. Complement activation induced by human C-reactive protein in mildly acidic conditions. J Immunol 1990;145:650-654.
39. Jiang H, Robey FA, Gewurz H. Localization of sites through which C-reactive protein binds and activates complement to residues 14-26 and 76-92 of the human Clq A chain. J Exp Med 1992;175:1373-1379.
40. Filep JG, Herman F, Kelernen E, Foldes-Filep E. C-reactive protein inhibits binding of platelet-activating factor to human platelets. Thromb Res 1991;61:411-421.
41. Robey RA, Jones KD, Tanaka T, Liu TY. Binding of C-reactive protein to chromatin and nucleosome core particles. A possible role of C-reactive protein. J Biol Chem 1984;259:7311-7316.
42. Jewell WS, Marnell LL, Rokeach LA, Du Clos TW. C-reactive protein (CRP) binding to the Sm-D protein of snRNPS. Identification of a short polypeptide binding region. Molec Immunol 1993;30:701-708.
43. Tseng J, Mortensen RF. The effect of human C-reactive protein on the cell-attachment activity of fibronectin and laminin. Exp Cell Res 1989;180:303-313.
44. Pepys MB, Rowe IF, Baltz ML. C-reactive protein: binding to lipids and lipoproteins. Int Rev Exp Path 1985;27:83-111.
45. Walsh MT, Divane A, Whitehead AS. Fine mapping of the human pentraxin gene region on chromosome 1q23. Immunogenetics 1996;44:62-69.
46. Weinhold B, Ruther U. Interleukin-6-dependent and -independent regulation of the human C-reactive protein gene. Biochem J 1997;327:425-429.
47. Yiangou M, Paraskeva E, Hsieh CC, Markou E, Victoratos P, Scouras Z, Papaconstantinou J. Induction of a subgroup of acute phase protein genes in mouse liver by hyperthermia. Biochim Biophys Acta 1998;1396:191-206.
48. Dodd SM, Martin JE, Swash M, Mather K. Expression of heat shock protein epitopes in renal disease. Clin Nephrol 1993;39:239-244.
49. Dinda AK, Mathur M, Guleria S, Saxena S, Tiwari SC, Dash SC. Heat shock protein (HSP) expression and proliferation of tubular cells in end stage renal disease with and without haemodialysis. Nephrol Dial Transplant 1998;13:99-105.
50. Craddock PR, Fehr J, Brigham KL, Kronenberg RS, Jacob HS. Complement and leukocyte-mediated pulmonary dysfunction in hemodialysis. N Engl J Med 1977;296:769-774.
51. Chenoweth DE, Cheung AK, Henderson LW. Anaphylatoxin formation during hemodialysis: Effect of different dialyser membranes. Kidney Int 1983;24:764-769.
52. Honkanen E, Gronhagen-Riska C, Teppo AM, Maury CP, Meri S. Acute-phase proteins during hemodialysis: correlations with serum interleukin-1β levels and different dialysis membranes. Nephron 1991;57:283-287.
53. 2 microglobulin. Int J Artif Organs 1994;17:337-344.
54. Vaziri ND, Kaupke CJ, Yousefi S, Gonzales E, Cesario TC. Cytokine levels during hemodialysis. ASAIO Trans 1991;37:M389-391.
55. Grooteman MP, Nube MJ, Daha MR, Van Limbeek J, van Deuren M, Schoorl M, Bet PM, Van Houte AJ. Cytokine profiles during clinical high-flux dialysis: no evidence for cytokine generation by circulating monocytes. J Am Soc Nephrol 1997;8:1745-1754.
56. Brown JH, Hunt LP, Vites NP, Short CD, Gokal R, Mallick NP. Comparative mortality from cardiovascular disease in patients with chronic renal failure. Nephrol Dial Transplant 1994;9:1136-1142.
57. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Plasma concentration of C-reaccive protein and risk of developing peripheral vascular disease. Circulation 1998;97:425-428.
58. Ridker PM, Glynn RJ, Hennekens CH. C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. Circulation 1998;97:2007-2011.
59. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997;336:973-979.
60. Koenig W, Sund M, Frölich M, Fischer H-G, Löwel H, Döring A, Hutchinson WL, Pepys MB. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men. Circulation 1999;99:237-242.
61. Ridker PM, Buring JE, Shih J, Matias M, Hennekens CH. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 1998;98:731-733.
62. Tracy RP, Lemaitre RN, Psaty BM, Ives DG, Evans RW, Cushman M, Meilahn EN, Kuller LH. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project. Arterioscler Thromb Vasc Biol 1997;17:1121-1127.
63. HarrisTB, Ferrucci L, Tracy RP, Corti MC, Wacholder S, Ettinger WH Jr, Heimovitz H, Cohen HJ, Wallace R. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med 1999;106:506-512.
64. Kuller LH, Tracy RP, Shaten J, Meilahn EL for the MRFIT Research Group. Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Am J Epidemiol 1996;144:537-547.
65. Haverkate F, Thompson SG, Pyke SD, Gallimore JR, Pepys MB. Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Lancet 1997;349:462-466.
66. Rebuzzi AG, Quaranta G, Liuzzo G, Caligiuri G, Lanza GA, Gallimore JR, Grillo RL, Cianflone D, Biasucci LM, Maseri A. Incremental prognostic value of serum levels of troponin T and C-reactive protein on admission in patients with unstable angina pectoris. Am J Cardiol 1998;82:715-719.
67. Pietila KO, Harmoinen AP, Jokiniitty J, Pasternack AI. Serum C-reactive protein concentration in acute myocardial infarction and its relationship to mortality during 24 months of follow-up in patients under thrombolytic treatment. Eur Heart J 1996;17:1345-1349.
68. Mendall MA, Patel P, Asante M, Ballam L, Morris J, Strachan DP, Camm AJ, Northfield TC. Relation of serum cytokine concentrations to cardiovascular risk factors and coronary heart disease. Heart 1997;78:273-277.
69. Hatanaka K, Li XA, Masuda K, Yutani C, Yamamoto A. Immunohistochemical localization of C-reactive protein-binding sites in human atherosclerotic aortic lesions by a modified streptavidin-biotin-staining method. Pathol Int 1995;45:635-641.
70. Zhang YX, Cliff WJ, Schoefl GI, Higgins G. Coronary C-reactive protein distribution: its relation to development of atherosclerosis. Atherosclerosis 1999;145:375-379.
71. Koenig W, Wanner C. C-reactive protein and coronary artery disease - what is the link? Nephrol Dial Transplant 1999;14:2798-2800.
72. Lowrie EG. Acute-phase inflammatory process contributes to malnutrition, anemia, and possibly other abnormalities in dalysis patients. Am J Kidney Dis 1998;32:5105-112.
73. Lowrie EG. Conceptual model for a core pathobiology of uremia with special reference to anemia, malnourishment, and mortality among dialysis patients. Semin Dial 1997;10:115-129.
74. Owen WF, Lowrie EG. C-reactive protein as an outcome predictor for maintenance hemodialysis patients. Kidney Int 1998;54:627-636.
75. Ikizler TA, Wingard RL, Harvell J, Shyr Y, Hakim RM. Association of morbidity with markers of nutrition and inflammation in chronic hemodialysis patients: A prospective study. Kidney Int 1999;55:1945-1951.
76. Iseki K, Tozawa M, Yoshi S, Fukiyama K. Serum C-reactive protein (CRP) and risk of death in chronic dialysis patients. Nephrol Dial Transplant 1999; 14:1956-1960.
77. Noh H, Lee SW, Kang SW, Shin SK, Choi KH, Lee HY, Han DS. Serum C-reactive protein: A predictor of mortality in continuous ambulatory peritoneal dialysis patients. Perit Dial Int 1998;18:387-394.
78. Stenvinkel P, Heimburger O, Tuck CH, Berglund L. Apo(a)-isoform size, nutritional status and inflammatory markers in chronic renal failure. Kidney Int 1998;53:1336-1342.
79. Qureshi AR, Alvestrand A, Danielsson A, Divino-Filho JC, Gutierrez A, Lindholm B, Bergstrom J. Factors predicting malnutrition in hemodialysis patients: a cross-sectional study. Kidney Int 1998;53:773-782.
80. Kaysen GA, Yeun J, Depner T. Albumin synthesis, catabolism and distribution in dialysis patients. Mineral Electrolyte Metab 1997;23:218-224.
81. Gunnell J, Yeun JY, Depner TA, Kaysen GA. Acute-phase response predicts erythropoietin resistance in hemodialysis and peritoneal dialysis patients. Am J Kidney Dis 1999;33:63-72.
82. Bárány P, Divino Filho JC, Bergström J. High C-reactive protein is a strong predictor of resistance to erythropoietin in hemodialysis patients. Am J Kidney Dis 1997;29:565-568.
83. Beguin Y, Loo M, R'Zik S, Sautois B, Lejeune F, Rorive G, Fillet G. Early prediction of response to recombinant human erythropoietin in patients with the anemia of renal failure by serum transferrin receptor and fibrinogen. Blood 1993;82:2010-2016.
84. Hartmann A, Eide TC, Fauchald P, Bentdal O, Herbert J, Gallimore JR, Pepys MB. Serum amyloid A protein is a clinically useful indicator of acute renal allograft rejection. Nephrol Dial Transplant 1997;12:161-166.
85. Steinhoff J, Buhner U, Feddersen A, Wood WG, Preuss R, Fricke L, Faerber P, Dodt C, Hoyer J, Sack K. C-reactive protein in the urine. The differential diagnosis of renal functional disorders following kidney transplantation. Deutsch Med Wochenschr 1992;117: 894-899.
86. Evevquoz D, Rosman J, Reichenstein T, Garzoni D, Rohrer W, Thiel G. C-reactive protein and early diagnosis of kidney transplant rejection. Schweiz Med Wochenschr 1993;123:1837-1842.
87. Steinhoff J, Buhner U, Feddersen A, Wood WG, Wiedemann G, Preuss R, Fricke L, Farber P, Hoyer J, Sack K. Analysis of C-reactive protein in urine as an aid in the clinical diagnosis of disturbed renal transplant function. Transplant Proc 1992;24:2735-2737.
88. Steinhoff J, Einecke G, Niederstadt C, de Groot K, Fricke L, Machnik H, Sack K. Renal graft rejection or urinary tract infection? The value of myeloperoxidase, C-reactive protein, and alpha2-macroglobulin in the urine. Transplantation 1997;64:443-447.
89. Gendrel D. Urinary tract infection and biological markers: C-reactive protein, interleukins and procalcitonin. Arch Pediatr 1998;5 Suppl 3:269-273.
90. Jaye DL, Wakes KB. Clinical applications of C-reactive protein in pediatrics. Pediatr Infect Dis J 1997;16:735-746.
91. Han DS, Lee SW, Kang SW, Choi KH, Lee HY, Cho EY, Lee JH. Factors affecting low values of serum albumin in CAPD patients. Adv Perit Dial 1996; 12:288-292.
92. Goldwasser P, Mittman N, Antignani A, Burrell D, Michel MA, Collier J et al. Predictors of mortality in hemodialysis patients. J Am Soc Nephrol 1993;3: 1613-1622.
93. Lowrie EG, Lew NL. Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities. AmJ Kidney Dis 1990;15:458-482.
94. Pereira BJG, Shapiro L, King AJ, Falagas ME, Strom JA, Dinarello CA. Plasma levels of IL-1β, TNFα, and their specific inhibitors in undialyzed chronic renal failure, CAPD, and hemodialysis patients. Kidney Int 1994;45:890-896.
95. Guarnieri G, Togigo G, Fiotti N, Ciocci B, Situlin R, Giansante C, Vasile A, Carraro M, Faccini L, Biolo G. Mechanisms of malnutrition in uremia. Kidney Int 1997(Suppl2);52:S41-44.
96. Nakanishi I, Mountabarrik A, Okada N, Kitamura E, Hayashi A, Syouji T, Namiki M, Ishibashi M, Zaid D, Tsubakihara Y. Interleukin-8 in chronic renal failure and dialysis patients. Nephrol Dial Transplant 1994; 9:1435-1442.
97. Herbelin A, Ureña P, Nguyen AT, Zingraff J, Descamps-Latscha B. Elevated circulating levels of interleukin-6 in patients with chronic renal failure. Kidney Int. 1991; 39:954-960.